Japan has emerged as a premier destination for clinical trials, attracting global pharmaceutical companies and research organizations due to its advanced medical infrastructure, highly skilled workforce, and robust regulatory framework. With a rapidly aging population and a high prevalence of chronic diseases, Japan offers a unique environment for conducting clinical research. The country’s strict compliance […]
Read More →The role of IOR & EOR services is becoming crucial in optimizing clinical trials in Japan. Clinical trials are essential for the development of new drugs and medical devices. Japan, being a significant player in the pharmaceutical industry, has become an attractive location for conducting clinical trials. This is due to its diverse patient population, […]
Read More →Medical device regulations vary from country to country, and this is not different in Japan. To register your medical device in Japan, you need to look for these top 6 considerations to make your registration process easy. Japan is a global economic powerhouse with one of the largest medical device markets. In terms of US […]
Read More →If you plan to register a healthcare product in Japan, previously you would need an In-country caretaker system. After the revision of the Pharmaceuticals and Medical Device (PMC) Act, the Marketing Authorization Holder (MAH) and Designated Marketing Authorization Holder (DMAH).replaces the In-country caretaker system The foreign manufacturer who plans to register their products in Japan […]
Read More →Japan has the same regulations and practices for nutraceuticals, food, and beverage goods as any other nation. Legitimate safety regulations, regulatory protectionism, and customs taxes present manufacturers with significant obstacles when they attempt to enter the market. The Ministry of Health, Labour, and Welfare (MHLW) and Consumer Affairs Agency (CAA) are in charge of enforcing the Food […]
Read More →Globally many consider herbs and botanicals to be natural and therefore healthier and gentler than conventional drugs. Currently, 30% of prescription drugs are herbal and botanical drugs. Herbals and botanicals are used for the treatment and improvement of health and well-being. Many countries use herbal and botanical drugs traditionally for many years to generations. The […]
Read More →After changes in the regulatory system, Japan has become the largest market for clinical trials in the Asia-Pacific region for both local and global studies, and Japan is now a country of choice in clinical development maps. But still, you need a proper strategy to accelerate the drug development process in Japan. Previously it would […]
Read More →Getting the study drug at the right time is challenging for any clinical trial, and this is more prominent with multi-regional clinical trials. To import and have the IMPs and ancillaries at the clinical trial sites in time, the sponsors need to have the right people, processes, facilities, and technology in place. Note: This article […]
Read More →Japan is one of the world’s leading cosmetic and personal care products (beauty products) markets. The experts assume the beauty and personal care products market to grow at a CAGR of 3.5% over the next five years. Cosmetics shipments within Japan generate a market value of around 2.7 trillion Japanese yen. Due to this market […]
Read More →The conduct of clinical trials is a critical process. Along with resource hiring, it also requires materials for different activities. Some of these materials can be investigational products. But, a vast number of products could be non-investigational products necessary for the conduct of clinical trials. It becomes critical to plan for procurement or import of […]
Read More →